Cost-effectiveness analysis of neoadjuvant immune checkpoint inhibition (ICI) versus cisplatin-based chemotherapy (CBC) in muscle-invasive bladder cancer (MIBC).

被引：0
|
作者：
Khaki, Ali Raza [1 ]
Shan, Yong [2 ]
Nelson, Richard [3 ]
Kaul, Sapna [2 ]
Gore, John L. [1 ]
Grivas, Petros [1 ]
Williams, Stephen B. [2 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Univ Texas Med Branch, Galveston, TX 77555 USA
[3] Univ Utah, Salt Lake City, UT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 06期
关键词：
D O I：
10.1200/JCO.2021.39.6_suppl.419
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
419
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of neoadjuvant immune checkpoint inhibition vs. cisplatin-based chemotherapy in muscle invasive bladder cancer
    Khaki, Ali Raza
    Shan, Yong
    Nelson, Richard E.
    Kaul, Sapna
    Gore, John L.
    Grivas, Petros
    Williams, Stephen B.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (10) : 732.e9 - 732.e16
  • [2] Cost-effectiveness analysis of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer
    Stevenson, Scott M.
    Deibert, Chris M.
    McKiernan, James M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [3] Plasticity in muscle-invasive bladder cancer before and after cisplatin-based neoadjuvant chemotherapy
    Seiler, Roland
    Gibb, Ewan A.
    Takhar, Mandeep
    Van Kessel, Kim
    van Rhijn, Bas W. G.
    Winters, Brian
    Douglas, James
    Wang, Qiqi
    Choeurng, Voleak
    Erho, Nicholas
    Buerki, Christine
    Davicioni, Elai
    Sjodahl, Gottfrid
    Thalmann, George N.
    Zwarthoff, Ellen C.
    Boormans, Joost L.
    Dall'Era, Marc
    van der Heijden, Michiel S.
    Wright, Jonathan
    Black, Peter C.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (10) : 618 - 618
  • [4] Cisplatin-based neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC) in patients (pts) with impaired renal function.
    Koshkin, Vadim S.
    Barata, Pedro C.
    Zahoor, Haris
    Rybicki, Lisa A.
    Almassi, Nima
    Redden, Alicia M.
    Fergany, Amr Farouk
    Kaouk, Jihad
    Haber, Georges-Pascal
    Stephenson, Andrew J.
    Martin, Allison
    Allman, Kimberly D.
    Beach, Jennifer
    Ornstein, Moshe Chaim
    Gilligan, Timothy D.
    Garcia, Jorge A.
    Rini, Brian I.
    Grivas, Petros
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [5] Efficacy of Split Schedule Versus Conventional Schedule Neoadjuvant Cisplatin-Based Chemotherapy for Muscle-Invasive Bladder Cancer
    Osterman, Chelsea K.
    Babu, Dilip S.
    Geynisman, Daniel M.
    Lewis, Bianca
    Somer, Robert A.
    Balar, Arjun V.
    Zibelman, Matthew R.
    Guancial, Elizabeth A.
    Antinori, Gianna
    Yu, Shun
    Narayan, Vivek
    Guzzo, Thomas J.
    Plimack, Elizabeth R.
    Vaughn, David J.
    Fung, Chunkit
    Mamtani, Ronac
    ONCOLOGIST, 2019, 24 (05): : 688 - 690
  • [6] Perioperative cisplatin-based chemotherapy for muscle-invasive bladder cancer: a decision analysis
    Luca Afferi
    Beate Jahn
    Amar H. Kelkar
    Stijntje W. Dijk
    Zach M. Feldman
    Zachary J. Ward
    Marco Moschini
    Richard Cathomas
    Joaquim Bellmunt
    Andrea Gallioli
    Alberto Breda
    Christian D. Fankhauser
    Agostino Mattei
    Steven L. Chang
    Uwe Siebert
    World Journal of Urology, 43 (1)
  • [7] COST EFFECTIVENESS ANALYSIS OF NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER
    Stevenson, Scott
    Deibert, Chris
    McKiernan, James
    JOURNAL OF UROLOGY, 2013, 189 (04): : E170 - E170
  • [8] Efficacy of split schedule (SS) vs conventional schedule (CS) neoadjuvant cisplatin-based chemotherapy for muscle-invasive bladder cancer (MIBC)
    Osterman, Chelsea K.
    Babu, Dilip Sankar
    Geynisman, Daniel M.
    Lewis, Bianca
    Somer, Robert A.
    Balar, Arjun Vasant
    Zibelman, Matthew R.
    Guancial, Elizabeth A.
    Narayan, Vivek
    Guzzo, Thomas J.
    Plimack, Elizabeth R.
    Vaughn, David J.
    Fung, Chunkit
    Mamtani, Ronac
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Cost-effectiveness of neoadjuvant chemotherapy before radical cystectomy for muscle-invasive bladder cancer
    Stevenson, Scott M.
    Danzig, Matthew R.
    Ghandour, Rashed A.
    Deibert, Christopher M.
    Decastro, G. Joel
    Benson, Mitchell C.
    McKiernan, James M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (08) : 1172 - 1177
  • [10] Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
    Guancial, Elizabeth A.
    Kilari, Deepak
    Xiao, Guang-Qian
    Abu-Farsakh, Sohaib H.
    Baran, Andrea
    Messing, Edward M.
    Kim, Eric S.
    PLOS ONE, 2016, 11 (05):
12345